BIRC5 and neoplasm: Tackling the advantageous properties of graphene oxide (GO), Chen et al. [52] have modified it with chitosan and a tumor-specific monoclonal antibody (anti-EpCAM) for the delivery of survivin siRNA (Figure 5).